0001209191-24-004612.txt : 20240306
0001209191-24-004612.hdr.sgml : 20240306
20240306201841
ACCESSION NUMBER: 0001209191-24-004612
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240304
FILED AS OF DATE: 20240306
DATE AS OF CHANGE: 20240306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hassard James
CENTRAL INDEX KEY: 0001799357
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 24727840
MAIL ADDRESS:
STREET 1: 177 E COLORADO BLVD
STREET 2: STE 700
CITY: PASADENA
STATE: CA
ZIP: 91105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 263744114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-450-6464
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-03-04
0
0001658247
Crinetics Pharmaceuticals, Inc.
CRNX
0001799357
Hassard James
C/O CRINETICS PHARMACEUTICALS, INC.
6055 LUSK BOULEVARD
SAN DIEGO
CA
92121
0
1
0
0
Chief Commercial Officer
0
Common Stock
2024-03-04
4
A
0
17000
0.00
A
31000
D
Stock Option (right to buy)
43.51
2024-03-04
4
A
0
63000
0.00
A
2034-03-03
Common Stock
63000
63000
D
The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2025.
The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 4, 2024.
/s/ Marc Wilson, as attorney-in-fact
2024-03-06